Via interacting with ataxia-telangiectasia-mutated (ATM) [79] and p300/cAMP response element-binding protein (CREB) [11], TCL1A has been linked to contributing to accelerated tumorigenic NF-κB signaling, as important in CLL pathogenesis. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.